Form 4: MindMed's Chief Medical Officer Sells Shares to Cover Tax Obligations

Daniel Karlin, Chief Medical Officer of Mind Medicine (MindMed) Inc., sold 6,836 common shares on March 25, 2025, to cover withholding tax obligations related to vested restricted stock units.

Summary

• On March 25, 2025, Daniel Karlin, the Chief Medical Officer of Mind Medicine (MindMed) Inc., sold 6,836 common shares of the company.
• The sale was executed to satisfy withholding tax obligations associated with the settlement of vested restricted stock units.
• The shares were sold at a weighted average price of $6.74, with individual transactions ranging from $6.67 to $6.79.
• Following the transaction, Karlin still beneficially owns 446,177 common shares of MindMed.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider share sale for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation or tax obligations. The disclosure provides transparency into the transactions of key personnel.

Stakeholder Impact

• The sale of shares by a company officer could be perceived neutrally or slightly negatively by shareholders, depending on their interpretation of the reasons behind the sale.

Key Dates

Keywords

MindMed, MNMD, Daniel Karlin, Chief Medical Officer, Form 4, Share Sale, Restricted Stock Units, Tax Obligations, Beneficial Ownership